This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

The pharma majors consolidated net profit increased 15.04% to Rs 2,903.38 crore on 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24. The scrip was down 0.06% to ...

Manipur Police recently arrested 15 insurgent cadres from various groups in multiple raids, involving extortion and illegal arms activities. Stringent security measures have been implemented, and the ...

In the last month, the price declined by 7.76%. ETMarkets.com Lupin share price: The company has launched its Rivaroxaban Tablets USP, 2.5mg, in the United States. The shares of Indian pharmaceutical ...

On Friday, Lupin launched rivaroxaban tablets USP, 2.5 mg, in the US market. This was followed after the final approval from the US Food and Drug Administration (US FDA) for its abbreviated new ...

Citi said the company's announcement of generic Rivaroxaban 2.5 mg (Xarelto 2.5mg) tablets in the US is an "at risk" launch as the patent litigation is still ongoing. The patent will expire in 2039.

Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application (ANDA) from ...

The No. 15-ranked Missouri Tigers kept their pedal on the gas in their regular season finale against No. 19 Kentucky, but failed to catch up after the Wildcats outpaced the Tigers in the first half.

In sensitivity analysis limited to the standard dose of DOACs, the decreased risk of ischemic stroke for upper GI ESD with rivaroxaban (OR, 0.15) and apixaban (OR, 0.12) vs dabigatran was ...

An icon of a desk calendar. An icon of a circle with a diagonal line across. An icon of a block arrow pointing to the right. An icon of a paper envelope. An icon of the Facebook "f" mark. An icon ...

The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received final approvals for Lenalidomide capsules and Dasatinib tabs from USFDA ...